The main published Phase 2 obesity study looked at retatrutide in adults with obesity, or overweight with at least one weight-related condition
The conventional concern that glucagon raises blood glucose and would offset the glucose-lowering goal of GLP-1/GIP agonism is addressed in the published mechanism literature by examining the tissue-specific and timing-specific actions of each receptor arm
For real user experiences and program outcomes, see consumer insights on Brello Health
Serving as copywriter and editor, he has written 400 blogs and has been involved with the launch of 32 new supplements
We highly encourage you to listen to both of these episodes where we dive further into metabolic health, the importance of balance blood sugar, food addiction, Susans weight loss Program, Bright Line Eating, and so much more
Moreover, the magnitude of WL with retatrutide also exceeded that seen with other pipeline multi-agonists such as CagriSema (cagrilintide, an amylin agonist, in combination with semaglutide), mazdutide and survodutide (Fig